Skip to main content

Table 4 Correlation of anti-Hsp70 and anti-Hsp60 with symptom severities

From: Plasma antibodies against heat shock protein 70 correlate with the incidence and severity of asthma in a Chinese population

Symptom Severity No. Anti-Hsp70 No. (%) Anti-Hsp60 No. (%)
   1:10 1:20 1:40 1:80 1:10 1:20 1:40 1:80
Step1: intermittent 30 2 (6.7) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Step2: mild persistent 36 10 (27.8) 5 (13.9) 2 (5.6) 1 (2.8) 3 (8.3) 1 (2.8) 1 (2.8) 1 (2.8)
Step3&4 moderate & severe persistent** 29 20 (69.0) 14 (48.3) 11 (37.9) 8 27.6) 14 (48.3) 5 (17.2) 4 (14.0) 4 (14.0)
R value*   0.809 0.958 0.968 0.959 0.954 0.864 0.947 0.947
P value*   0.000 0.000 0.000 0.001 0.000 0.000 0.016 0.016
  1. * The analyses of correlation of symptom severities with different dilutions of anti-Hsp70 and anti-Hsp60
  2. **: there are two severe persistent patients with asthma